Table 3

Number of patients fulfilling the criteria and the sensitivity and specificity of each criterion or of combination of criteria for the discrimination between RRMS and MOG-ab NMOSD

Number of participantsCriterion (a): Lesion adjacent to the body of a LV and inferior temporal lobe lesionCriterion (b): U-fibre lesionsCriterion (c): Dawson's fingersFull criteria (a, b or c)
MOG-ab NMOSD, n210101
RRMS, n4432133640
Sensitivity, %72.729.681.890.9
Specificity, %10095.210095.2
PPV, %10092.910097.6
NPV, %63.639.272.483.3
  • MOG, myelin oligodendrocyte glycoprotein; NMOSD, neuromyelitis optica spectrum disorders.